Stability indicating LC-MS/MS method and validation of Selexipag impurities and identification of its force degradation products
Selexipag belongs to a class of medicines known as IP prostacyclin receptor agonists used to treat pulmonary arterial hypertension. A simple and sensitive LC-MS/MS method has been developed for the identification of process related impurities in Selexipag API. The method was developed using a Zorbax...
Main Authors: | Pranavkumar Shah, Sanjay Hadiyal, Bhavin Dhaduk |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Results in Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715623002618 |
Similar Items
-
An innovative impurity profiling of Avanafil using LC and LC-MS/MS with in-silico toxicity prediction
by: Patel Mital, et al.
Published: (2020-08-01) -
Selexipag in pregnancy and pulmonary arterial hypertension
by: Sweta Mohanty, et al.
Published: (2023-01-01) -
Development and validation of an LC-MS/MS method for simultaneous determination of three organic azido impurities in tetrazole-containing sartans
by: Wisut Wichitnithad, et al.
Published: (2023-08-01) -
Trace Level Quantification of 4-Methyl-1-nitrosopiperazin in Rifampicin Capsules by LC-MS/MS
by: Xiaosha Tao, et al.
Published: (2022-02-01) -
Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
by: Hardin EA, et al.
Published: (2016-11-01)